Trypsin inhibitors demonstrate antioxidant activities, inhibit A549 cell proliferation, and increase activities of reactive oxygen species scavenging enzymes
Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role...
Saved in:
Published in | Indian journal of pharmacology Vol. 49; no. 2; pp. 155 - 160 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
India
Medknow Publications and Media Pvt. Ltd
01.03.2017
Medknow Publications & Media Pvt. Ltd Medknow Publications & Media Pvt Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line.
TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer.
TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells.
This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer. |
---|---|
AbstractList | Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line.
TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer.
TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells.
This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer. OBJECTIVES: Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line. MATERIALS AND METHODOLOGY: TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer. RESULTS: TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells. CONCLUSIONS: This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer. Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line.OBJECTIVESProtease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed to investigate antineoplastic and antioxidant activity of trypsin inhibitors (TIs) isolated from three plant sources and their inhibitory role in the cell line.TIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer.MATERIALS AND METHODOLOGYTIs were obtained from different plant sources. Antineoplastic potential on adenocarcinoma human alveolar basal epithelial cell line (A549) and normal Human Embryonic Kidney (HEK) was determined using MTT assay. Activities of antioxidant enzyme, nitric oxide scavenger, superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were assessed in cell lines incubated with and without TIs. The outcome was analyzed by spectrophotometer.TIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells.RESULTSTIs showed the higher cytotoxicity on A549 cells as compared to normal HEK cell line. TIs exhibited fair increase in antioxidant enzyme activity in A549 cells as compared to control. This might be one of the strategies of antineoplastic effect in cancer cells.This study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer.CONCLUSIONSThis study has reported the antioxidant and antineoplastic properties of these TIs for the first time in A549 cells (to the best of our knowledge). The results show that TIs possess ability to prevent cancer and diseases caused due to oxidative stress. Therefore, we conclude that TIs can be used as supplements along with the conventional drugs for increased efficacy in the treatment of diseases such as cardiovascular disease, atherosclerosis, and cancer. |
Audience | Academic |
Author | Shamsi, ToobaNaz Parveen, Romana Fatima, Sadaf |
AuthorAffiliation | Department of Biotechnology, Jamia Millia Islamia, New Delhi, India |
AuthorAffiliation_xml | – name: Department of Biotechnology, Jamia Millia Islamia, New Delhi, India |
Author_xml | – sequence: 1 givenname: ToobaNaz surname: Shamsi fullname: Shamsi, ToobaNaz – sequence: 2 givenname: Romana surname: Parveen fullname: Parveen, Romana – sequence: 3 givenname: Sadaf surname: Fatima fullname: Fatima, Sadaf |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28706328$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktvEzEUhS1URB-wZYkssWHRCWN7PHY2SFHFo6gSLMracjx3UkcTe7AnUcN_4b9yhzZNi4JmYdn-zvHce88pOQoxACGvWTmpWCne-2U_ufz63UgpDKufkRM2nepCKMmOyEnJpShUzcQxOc15WeK-mtYvyDHXqqwF1yfk93Xa9tkH6sONn_shpkwbWMWQh2QHoDYMPt76Bldq3eA3fvCQz3c4naEjddB1tE-x8y2gysdwjsIGIZfAZnikpLGleDbugcbb7QICzT248So7u4Gw8GFBIfzariC_JM9b22V4db-ekR-fPl5ffCmuvn2-vJhdFU5yMRStVVLLqm641SAqwSvNnVIaOzTXgjXKMd6Ucy5ZoxtRczVVVjLFVd0KbeetOCMf7nz79XwFjYOA1XemT35l09ZE683Tm-BvzCJuDFavKqHQ4N29QYo_15AHs_J5bIsNENfZsCkveVnqiiP69h90GdcpYHkjJVQtea331MJ2YHxoI77rRlMzwxlKxjUfvYoDFPYUx9BhUFqPx0_4yQEePxy5dwcFbx435qEjuwAhUN0BLsWcE7TG-eFvBNDZd4aVZsypwZyafU73P_Ig2zn_R_AH12jtBw |
CitedBy_id | crossref_primary_10_3390_molecules23061251 crossref_primary_10_1002_cbf_3845 crossref_primary_10_1080_19476337_2021_1971771 crossref_primary_10_3390_ijms22073543 crossref_primary_10_1016_j_lfs_2019_117044 crossref_primary_10_30901_2227_8834_2020_3_25_31 crossref_primary_10_1021_acs_jafc_3c08711 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd. Copyright Medknow Publications & Media Pvt. Ltd. Mar/Apr 2017 Copyright: © 2017 Indian Journal of Pharmacology 2017 |
Copyright_xml | – notice: COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd. – notice: Copyright Medknow Publications & Media Pvt. Ltd. Mar/Apr 2017 – notice: Copyright: © 2017 Indian Journal of Pharmacology 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.4103/ijp.IJP_553_16 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library (ProQuest) Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1998-3751 |
EndPage | 160 |
ExternalDocumentID | PMC5497437 A496512822 28706328 10_4103_ijp_IJP_553_16 |
Genre | Journal Article |
GroupedDBID | --- 29I 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ 8G5 96U AAYXX ABDBF ABJNI ABUWG ABVJJ ACGFO ACGFS ACIHN ACUHS ADBBV ADJBI ADRAZ AEAQA AENEX AFAZI AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BENPR BPHCQ BVXVI C1A CCPQU CITATION DIK DU5 DWQXO E3Z EBD EBS EJD EOJEC ESX F5P FRP FYUFA GNUQQ GUQSH GX1 H13 HH5 HMCUK HYE IAO IEA IHE IHR IL9 INH INR IOF ITC KQ8 M1P M2O M48 MK0 O5R O5S OBODZ OK1 OVD OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBI RMW RNS RPM TEORI TR2 TUS UKHRP W2D XSB ~8M 2CU 3V. ABXLX CGR CUY CVF ECM EIF GROUPED_DOAJ M~E NPM PMFND 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c523t-fa758546d2a8e3432482c778410b831d7c12d0b251d8d362797a517276f38abf3 |
IEDL.DBID | M48 |
ISSN | 0253-7613 1998-3751 |
IngestDate | Thu Aug 21 13:49:20 EDT 2025 Thu Jul 10 22:34:00 EDT 2025 Fri Jul 25 23:09:45 EDT 2025 Tue Jun 17 21:03:02 EDT 2025 Thu Jun 12 23:47:50 EDT 2025 Tue Jun 10 20:14:22 EDT 2025 Thu Jan 02 23:12:02 EST 2025 Tue Jul 01 01:12:24 EDT 2025 Thu Apr 24 22:53:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | lung cancer Antioxidant protein protein protease inhibitors |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c523t-fa758546d2a8e3432482c778410b831d7c12d0b251d8d362797a517276f38abf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4103/ijp.IJP_553_16 |
PMID | 28706328 |
PQID | 1923765268 |
PQPubID | 28295 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5497437 proquest_miscellaneous_1920200842 proquest_journals_1923765268 gale_infotracmisc_A496512822 gale_infotracgeneralonefile_A496512822 gale_infotracacademiconefile_A496512822 pubmed_primary_28706328 crossref_citationtrail_10_4103_ijp_IJP_553_16 crossref_primary_10_4103_ijp_IJP_553_16 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-03-01 |
PublicationDateYYYYMMDD | 2017-03-01 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | India |
PublicationPlace_xml | – name: India – name: Pondicherry |
PublicationTitle | Indian journal of pharmacology |
PublicationTitleAlternate | Indian J Pharmacol |
PublicationYear | 2017 |
Publisher | Medknow Publications and Media Pvt. Ltd Medknow Publications & Media Pvt. Ltd Medknow Publications & Media Pvt Ltd |
Publisher_xml | – name: Medknow Publications and Media Pvt. Ltd – name: Medknow Publications & Media Pvt. Ltd – name: Medknow Publications & Media Pvt Ltd |
References | 21516412 - Methods Mol Biol. 2011;731:237-45 27506886 - Food Funct. 2016 Sep 14;7(9):3868-79 22916809 - Br J Nutr. 2012 Aug;108 Suppl 1:S135-44 19574654 - Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt 7):736-8 15972265 - Comp Biochem Physiol A Mol Integr Physiol. 2005 Oct;142(2):111-7 27043143 - PLoS One. 2016 Apr 04;11(4):e0152925 26955746 - Int J Biol Macromol. 2016 Oct;91:1120-33 23306898 - Appl Biochem Biotechnol. 2013 Feb;169(4):1306-14 27379315 - Int Sch Res Notices. 2014 Oct 29;2014:568081 21969071 - Arch Toxicol. 2012 Feb;86(2):293-304 21749277 - Free Radic Res. 2011 Oct;45(10):1154-61 22454771 - Biochem Res Int. 2012;2012:454368 26273424 - Oxid Med Cell Longev. 2015;2015:750798 25061412 - Saudi Pharm J. 2014 Jul;22(3):264-72 27461591 - J Cancer Res Ther. 2016 Apr-Jun;12 (2):438-46 26659465 - PLoS One. 2015 Dec 11;10(12):e0144509 23558240 - Pancreas. 2013 May;42(4):614-21 27410459 - PLoS One. 2016 Jul 13;11(7):e0158942 26907338 - Nutrients. 2016 Feb 23;8(3):110 23305162 - BMC Complement Altern Med. 2013 Jan 10;13:12 |
References_xml | – reference: 25061412 - Saudi Pharm J. 2014 Jul;22(3):264-72 – reference: 27461591 - J Cancer Res Ther. 2016 Apr-Jun;12 (2):438-46 – reference: 26907338 - Nutrients. 2016 Feb 23;8(3):110 – reference: 22454771 - Biochem Res Int. 2012;2012:454368 – reference: 27043143 - PLoS One. 2016 Apr 04;11(4):e0152925 – reference: 27379315 - Int Sch Res Notices. 2014 Oct 29;2014:568081 – reference: 26273424 - Oxid Med Cell Longev. 2015;2015:750798 – reference: 21749277 - Free Radic Res. 2011 Oct;45(10):1154-61 – reference: 15972265 - Comp Biochem Physiol A Mol Integr Physiol. 2005 Oct;142(2):111-7 – reference: 27506886 - Food Funct. 2016 Sep 14;7(9):3868-79 – reference: 23306898 - Appl Biochem Biotechnol. 2013 Feb;169(4):1306-14 – reference: 27410459 - PLoS One. 2016 Jul 13;11(7):e0158942 – reference: 21516412 - Methods Mol Biol. 2011;731:237-45 – reference: 26659465 - PLoS One. 2015 Dec 11;10(12):e0144509 – reference: 23305162 - BMC Complement Altern Med. 2013 Jan 10;13:12 – reference: 19574654 - Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt 7):736-8 – reference: 22916809 - Br J Nutr. 2012 Aug;108 Suppl 1:S135-44 – reference: 23558240 - Pancreas. 2013 May;42(4):614-21 – reference: 26955746 - Int J Biol Macromol. 2016 Oct;91:1120-33 – reference: 21969071 - Arch Toxicol. 2012 Feb;86(2):293-304 |
SSID | ssj0025496 |
Score | 2.150488 |
Snippet | Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This study aimed... OBJECTIVES: Protease inhibitors are one of the most promising and investigated subjects for their role in pharmacognostical and pharmacological studies. This... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 155 |
SubjectTerms | A549 Cells Acids Antineoplastic Agents - pharmacology Antioxidants Antioxidants (Nutrients) Antioxidants - pharmacology Apoptosis Biotechnology Cancer Cell adhesion & migration Cell cycle Cell growth Cell Proliferation - drug effects Cell Survival - drug effects Cytotoxicity Enzymes Garlic Glutathione Peroxidase - metabolism Glutathione Transferase - metabolism HEK293 Cells Humans Metastasis Oxidative stress Phaseolus Physiological aspects Reactive oxygen species Reactive Oxygen Species - metabolism Seeds Signal transduction Superoxide Dismutase - metabolism Trypsin inhibitors Trypsin Inhibitors - pharmacology Vigna |
SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9NAEF1BuXBBfBMoaJFQuMTU9tpe94QiRFV6QDmkUm6W98PUiDqmTlHNf-G_Mm_txDECTpGys5atmZ19szvzhrE3ZBIEQiWtNJH7XqSVAAek8VSgaH9SRWStS5D9nJyeR2ereNUfuDV9WuXWJzpHbdYaZ-RHQCIyATnJ-_q7h65RuF3tW2jcZndAXQarlqsh4KLYx91VhrHwKFwXHWljFPjiqPxav_t0tsjiWGTodb63Kf3pmvf2pnHe5N5GdHKf3esRJJ93Kn_AbtnqIZsuOgrqdsaXQ0VVM-NTvhjIqdtH7Nfyqq2bsuJldVGqEr12uLGXQIkgjeA5sh9vSkO_HDUPPxzj6mwrzuf0tRyn_bxGv5_CdhY0o4mGhIBBG7s3k68LTv85r8rXNy3ZK0d1J4YajV726JLEbfWzvbTNY3Z-8nH54dTrWzR4miLYjVfkiDeixIR5alGjGqWhlrjL9FUqAiN1EBpfEYgyqaG9Uh7LPAZmSgqR5qoQT9hBta7sM8YTk5sgiXUaWFDai1SR6zMU0KnkOFJGTpi31VGme_5ytNH4llEcA51mpNNs0OmEvd3J1x1zx78lofIMS5qeqPO-MoHeC-RY2Ryc-gHybSdsOpL80lGD_03wcCRIa1aPh7fWlfU-o8kGC5-w17thzEQeXGXX107GR8ZKRI942hnj7uPclbUIabYcmelOAEzi45GqvHCM4mQ6hCTl8_-_1gt2NwSocRl4h-xgc3VtXxIk26hXbt39BqDDOW8 priority: 102 providerName: ProQuest |
Title | Trypsin inhibitors demonstrate antioxidant activities, inhibit A549 cell proliferation, and increase activities of reactive oxygen species scavenging enzymes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28706328 https://www.proquest.com/docview/1923765268 https://www.proquest.com/docview/1920200842 https://pubmed.ncbi.nlm.nih.gov/PMC5497437 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7R9sIF8ca0RIuEwiUOsdf2uicUUKtSiSpCiZTbyutdU6PWSeMUxfwX_iszfiVG4cIpUnbGijMzO99oZ78BeIcugSBUYKTxaGR7seLEAalt5SjMTyrxjCkbZK-Ci5l3Offn2_6n-g_M95Z2NE9qtroZbu6KjxjwiF-HnjPiH9Ify-GXy4n0fS6d4ACOMCsJmmbw1WtPFKgOKs8tXZ_bWLrzisBxjz7RA9PhH6cB7Tu56u8deydlddspd_LT-WN4VANLNq484Qk8MNlT6E8qZupiwKbbi1b5gPXZZMtZXTyD39NVsczTjKXZdapSGsHDtLkl8EhcEiyipshNqvGT0VWInyUR66ARZ2N8cUaHAGxJY4ASUznWABU1ChE0zc2OJlskDL8rN1u22BToxowufdJSHtOIexqexEz2q7g1-XOYnZ9NP1_Y9eQGO8bCdm0nEZUhXqDdKDR0ddUL3VjQEedIhdzRInZcPVKIrXSoMYWKUxH5BKWChIeRSvgLOMwWmXkFLNCRdgI_Dh1DTPc8VLgjarSQCk49pYUFdmMjGde05jRd40ZieUPmlWheuTWvBe9b-WVF6PFvSTK5JN_DJ8ZRfWEBfxdxZskxUe071IZrQb8j-b1iDN8neNIRxFCOu8uNd8kmEiRBcBEQK48Fb9tl0qT2uMws7kuZETWyePiIl5Uzti_XOLMFouOmrQARjHdXsvS6JBpH10GAKV7_t-YxPHQJBpU9eydwuF7dmzcI4taqBwdiLnpw9OnsavKtV8bqH8osTKk |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcoAL4k2gwCJBuMTU73UPCEVAlbSlyiGVclu8D1NXrW3qFGr-C3-B38jM2o5jBNx6ipSdXdma2Xl4Zr4h5CWIBDihDG6aF9uWL4WHGJDKEo4A-yQSX2tTIHsYTo78vUWw2CC_2l4YLKtsdaJR1CqX-I18Gz0RFiI4ybviq4VTozC72o7QqMViX1ffIWQr304_AH9fue7ux_n7idVMFbAkBF1LK4nRRfZD5caRxrZKP3Ilw_SbLSLPUUw6rrIF2H0VKVDvbIfFAZr5MPGiWCQenHuNXAfDa2OwxxZdgAexlsmNuoFnMbCTNUgkHOxtpyfFm-nejAeBx3G2-poR_NMUrNnCfp3mmuHbvU1uNR4rHdcidods6OwuGc5qyOtqROddB1c5okM668Cwq3vk5_y8Kso0o2l2nIoUZ_tQpc_QK0WQChpjteVlquCXYo_FN4PwOmrJ6RjelmJ2gRY4XyjRtcSOYKMCIvR5S722k-YJhf-MFqf5ZQX3g2I3KS6VMgbVjlOZqM5-VGe6vE-OroR5D8hmlmf6EaGhipUTBjJyNELoe5EAVasggBThji8UGxCr5RGXDV46ju045RA3IU858JR3PB2Q1yv6okYK-TclspyjCoETZdx0QsBzIRgXHyOGv4P1vQMy7FF-qaHI_0a41SMEHSH7y6108UZHlby7UQPyYrWMO7HuLtP5haGxsULGhyMe1sK4ejmTIvdc2M16YroiQOTy_kqWHhsEcxAd8FzZ4_8_1nNyYzL_dMAPpof7T8hNFx0qU_23RTaX5xf6KbiDS_HM3EFKPl_1pf8NAa9z2A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trypsin+inhibitors+demonstrate+antioxidant+activities%2C+inhibit+A549+cell+proliferation%2C+and+increase+activities+of+reactive+oxygen+species+scavenging+enzymes&rft.jtitle=Indian+journal+of+pharmacology&rft.au=Shamsi%2C+Tooba+Naz&rft.au=Parveen%2C+Romana&rft.au=Fatima%2C+Sadaf&rft.date=2017-03-01&rft.pub=Medknow+Publications+%26+Media+Pvt+Ltd&rft.issn=0253-7613&rft.eissn=1998-3751&rft.volume=49&rft.issue=2&rft.spage=155&rft.epage=160&rft_id=info:doi/10.4103%2Fijp.IJP_553_16&rft_id=info%3Apmid%2F28706328&rft.externalDocID=PMC5497437 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-7613&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-7613&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-7613&client=summon |